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The nuclear lamina, a protein network located under
the nuclear membrane, has during the past decade
found increasing interest due to its signiﬁcant involve-
ment in a range of genetic diseases, including the
segmental premature aging syndromes Hutchinson–
Gilford progeria syndrome, restrictive dermopathy,
and atypical Werner syndrome. In this review we
examine these diseases, some caused by mutations in
the LMNA gene, and their skin disease features.
Advances within this area might also provide novel
insights into the biology of skin aging, as recent data
suggest that low levels of progerin are expressed in
unaffected individuals and these levels increase
with aging.
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INTRODUCTION
Laminopathies are diseases caused by a heterogeneous family
of mutations either directly affecting the LMNA gene (causing
primary laminopathies Hegele, 2005)) or affecting genes coding
for B-type lamins, prelamin A processing proteins, or lamin-
binding proteins (causing secondary laminopathies (Broers
et al., 2006; Landires et al., 2007)). Four of these laminopathies
are classiﬁed as premature-aging syndromes: Hutchinson–
Gilford progeria syndrome (HGPS, Online Inheritance in Man
(OMIM) #176670), atypical progeroid syndrome, restrictive
dermopathy (RD, OMIM #275210), and atypical Werner
syndrome (OMIM #277700).
HGPS is a rare and fatal genetic disorder with a stark
phenotype of premature senility. Although ﬁrst described in
1886 by Hutchinson and in 1904 by Gilford (Hutchinson,
1886; Gilford, 1897), the genetic cause of progeria was found
only in 2003 (de Sandre-Giovannoli et al., 2003; Eriksson et al.,
2003). Numerous other mutations have since been found to
cause HGPS (Figure 1a) (Fukuchi et al., 2004; Dechat et al.,
2007; Moulson et al., 2007; Hisama et al., 2011; Reunert et al.,
2012); however, the vast majority of HGPS cases (490%) are
caused by the de novo c.1824C4T, p.G608G mutation in the
lamin A gene (Figure 1a) that results in the increased activation
of a cryptic splice site in exon 11 of LMNA. This increases the
production and accumulation of a partially processed prelamin
A protein, called progerin (Figure 1b) (Eriksson et al., 2003;
Goldman et al., 2004).
Patients with HGPS are born without noticeable symptoms;
however, they fail to thrive, and from ∼6 to 18 months of age
display sclerodermatous skin with patches that are hyper- or
hypopigmented, as well as a loss of subcutaneous fat. As the
ﬁrst signs of HGPS appear in the skin, and as the skin undergoes
the most marked change in patients, several groups have
performed research speciﬁcally on the effects of progerin in the
skin. Skin-speciﬁc symptoms include alopecia, dyspigmenta-
tion, and prominent veins followed by the occurrence of a thin
epidermis, dermal ﬁbrosis, and a loss of skin appendages (hair
follicles, sweat glands, and sebaceous glands), as well as the
development of tight skin over the abdomen and thighs by the
third year of life. Other early symptoms include short stature
and low body weight. Patients have a horse-riding stance, short
clavicles, osteolysis, and joint stiffness. These symptoms result
in an aged appearance. Death occurs by the early teenage
years, often caused by cardiovascular complications due to
atherosclerosis (Gillar et al., 1991; Rodríguez et al., 1999;
Eriksson et al., 2003; Merideth et al., 2008; Salamat et al.,
2010).
RD is a rare and lethal autosomal recessive disease, caused
by loss-of-function mutations in ZMPSTE24 (also referred to as
FACE1, OMIM #606480) (Navarro et al., 2014). The protein
product of ZMPSTE24 is a zinc metalloproteinase that is
involved in the processing of lamin A (Figure 1b). Skin histology
revealed thin epidermal layers with regular structure and a ﬂat
epidermal–dermal junction. Sebaceous glands and hair follicles
were immature and poorly developed, and the dermis showed
parallel collagen bundles and an almost total lack of elastic
ﬁbers (Khanna et al., 2008; Smigiel et al., 2010).
Children with RD show intrauterine growth retardation, as
well as a decreased fetal movement. After birth, they display a
characteristic thin, translucent, tight skin, lacking eyebrows
and eyelashes, joint contractures, respiratory insufﬁciency, a
small pinched nose, micrognathia, and mouth in a ﬁxed “o”
shape. Respiratory failure caused by the tight skin most often
leads to neonatal death within several weeks of birth (Mok
et al., 1990; Smigiel et al., 2010).
Atypical Werner syndrome was described ﬁrst by Otto
Werner in 1904. Unlike Werner syndrome, which is caused by
mutations in WRN (Yu et al., 1996), atypical Werner syndrome
is caused by mutations in other genes, with a minority of these
cases found to be caused by heterozygous mutations in LMNA
(Chen et al., 2003). Werner syndrome is called the “progeria of
the adult,” with symptoms emerging in the teenage years. The
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initial pubertal growth failure is later followed by skin atrophy,
ulcers, cataracts, atherosclerosis, hair graying and alopecia,
type 2 diabetes mellitus, and osteoporosis. Malignancies,
reduced fertility, and gonadal atrophy can also occur, with
cardiovascular disease and cancer being the most common
causes of death, occurring at a mean age of 54 years (Hisama
et al., 2011, 2012).
Progeroid diseases caused by LMNA mutations that are not
associated with characterized diseases are classiﬁed as
atypical progeroid syndromes. By deﬁnition, these diseases
have a varied disease pathology, running the gamut from
RD-like neonatally lethal tight-skin syndromes (Navarro et al.,
2004) to HGPS-like disorders with symptoms of growth
retardation, partially alopecia, skin atrophy, and diabetes
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Figure 1. Impaired lamin A/C in segmental progeroid syndromes. (a) A list of selected LMNA mutations causing atypical Werner syndrome (AWS), Hutchinson–
Gilford progeria syndrome (HGPS), and atypical progeroid syndrome (APS). Exons 1–9 and a section of 10 encode lamin C (lamin C–speciﬁc amino acids in
green). Lamin A results from alternative splicing using exons 1–12, without the lamin C–speciﬁc part of exon 10. Conserved α-helical regions of the central rod
domain are labeled coil 1/1B/2A+2B. Underlying numbers refer to primary sequence locations. NLS, nuclear localization signal. (b) Prelamin A maturation in
wild type, HGPS (and several APS), and restrictive dermopathy (RD). (c) Skin ﬁbroblast nuclei, blue (DNA), young/unaffected, aged/unaffected, and HGPS, far
right shows the HGPS nuclei in red (progerin).
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(Garg et al., 2009). In the more severe atypical progeroid
syndrome and with early onset, progerin accumulation occurs
at a greater level than in HGPS, thought to be a factor in the
increased severity of the disease (Moulson et al., 2007).
THE MOLECULAR GENETICS OF HGPS AND RD
To date, 464 different mutations from 2,251 individuals have
been identiﬁed in LMNA (The UMD-LMNA mutations
database, 2012). LMNA (OMIM #150330) consists of exons
1–12 and encodes prelamin A that is converted to lamin A
(Figure 1b). Lamin A is localized to the inner nuclear
membrane, where it gives shape, strength, and support to the
nucleus and regulates gene expression by binding DNA as well
as sequestering heterochromatin to the nuclear periphery. It has
also been associated with DNA replication and repair and
organization of nuclear pore complexes and chromatin (Broers
et al., 2006; Dechat et al., 2008; Dittmer et al., 2014).
The LMNA gene also produces lamin C and the minor AΔ10
and C2 proteins by alternative splicing within exon 10 (Lin and
Worman, 1993). The N-terminal head domain is encoded by
exon 1, exons 1–6 code the central rod domain, and the
C-terminal tail domain is encoded by exons 7–9. Exon 7 also
encodes a 6-amino-acid nuclear localization signal allowing
the protein to be imported into the nucleus (Figure 1a) (Fisher
and Chaudhary, 1986; Lin and Worman, 1993; Rout, 2001).
Exons 11 and 12 are speciﬁc to lamin A.
A-type lamins are only expressed in differentiated cells,
suggesting that they are instrumental in stabilizing differential
gene expression (Stick and Hausen, 1985; Lehner et al., 1987;
Röber et al., 1989; Zorenc, 1996). Lamins A and C are identical
for the initial 566 amino acids. Lamin C terminates with 6
unique amino acids, whereas lamin A has 98 unique amino
acids, ending in a CaaX motif on exon 12. This motif is key for
posttranslational processing. It is modiﬁed, aiding prelamin A
integration into the nuclear lamina, and subsequently removed
during the maturation of lamin A (Pendás et al., 2002;
Barrowman et al., 2008) that takes place in the nucleus (Lutz
et al., 1992).
Posttranslational modiﬁcation of prelamin A (Figure 1b):
(1) An initial prenylation step attaches a farnesyl or geranyl-
geranyl isoprenoid group to the cysteine of the CaaX motif
that lies at the C-terminal end of prelamin A.
(2) The -aaX amino acids of this motif are then removed by
the RCE1 or the FACE1 enzymes.
(3) The exposed C-terminal farnesylcysteine is then methy-
lated by a carboxymethyltransferase, isoprenylcysteine
carboxyl methyltransferase (Holtz et al., 1989).
(4) At the nuclear membrane, a ﬁnal cleavage step occurs as
FACE1 removes the carboxy-terminal 15 amino acids and
the farnesylcysteine methyl ester group from prelamin A,
resulting in mature Lamin A (Vergnes et al., 2004).
The mutated prelamin A produced in HGPS patients can
undergo the initial three steps of posttranslational maturation.
However, the G608G mutation (or the less common G608S,
V607V, or IVS11+1G4A; Figure 1a) results in the deletion of
150 nucleotides containing the second cleavage site
recognized by ZMPSTE24, and hence the fourth step cannot
be completed, resulting in a permanently farnesylated protein
(Figure 1b). This improperly processed protein, progerin, is
thought to cause the disease phenotype (Capell et al., 2005;
Young et al., 2005). In RD patient cells, the lack of a
functional ZMPSTE24 enzyme means that the ﬁnal cleavage
step cannot be performed and leads to the accumulation of a
farnesylated prelamin A (Figure 1b) (Smigiel et al., 2010).
Progerin remains erroneously farnesylated, causing it to
localize to the nuclear membrane, resulting in a disruption to
the nuclear laminar integrity and defects in nuclear structure
and function. HGPS patient ﬁbroblasts are characterized by
dysmorphic nuclei with altered size and shape, a thickened
nuclear lamina, a loss of peripheral heterochromatin, the
clustering of nuclear pores, as well as the presence of lobules,
wrinkles, and herniations of the nuclear envelope (Figure 1c)
(Eriksson et al., 2003; Goldman et al., 2004; Scafﬁdi and
Misteli, 2005). These defects worsen as the cell cultures are
passaged and are correlated with the intranuclear
accumulation of progerin (Goldman et al., 2004). A recent
study of Werner syndrome on human embryonic stem cells
showed changes in heterochromatin architecture that was
also found in mesenchymal stem cells from aged individuals,
adding to the evidence of heterochromatin disorganization as
a factor in normal aging (Zhang et al., 2015).
EVIDENCE FOR LAMIN INVOLVEMENT IN NORMAL
AGING
Progerin has been found not only in HGPS patients but also in
healthy aged individuals and normal cell lines (Scafﬁdi and
Misteli, 2006; Cao et al., 2007; McClintock et al., 2007;
Rodriguez et al., 2009). An increasing level of progerin in
passaged HGPS cells has also been shown to correlate to
the more severe defects seen in late-passage cells (Goldman
et al., 2004; Moulson et al., 2007) (Figure 2a). Naturally, the
question arises of whether pathological aging is rooted in the
accumulation of progerin over a lifetime of aging. Research in
this area has shown that progerin mRNA levels are consistent
between groups of young and aged individuals (Scafﬁdi and
Misteli, 2006). Skin ﬁbroblasts from healthy individuals grown
in culture, however, do show an increase in progerin mRNA
transcript levels with increased time in culture (Rodriguez
et al., 2009). Studies on ﬁbroblasts from healthy adults
showed that a small number of cell nuclei stained positively
for progerin and that this number increased with the number
of passages (Cao et al., 2007).
The in vivo studies have also shown the presence of
progerin in skin biopsies from unaffected individuals, with
progerin-positive nuclei found in dermal ﬁbroblasts and
terminally differentiated keratinocytes. In young adult skin
samples, progerin-positive ﬁbroblasts were localized near the
basement membrane and in the upper layers of the dermis;
however, in elderly skin, their numbers increase, and they are
also localized in the deep reticular dermis (McClintock et al.,
2007). An examination of cardiovascular tissues from HGPS
and non-HGPS aged tissues showed the presence of progerin
in both (Olive et al., 2010).
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ADULT STEM CELLS IN HGPS
One model for the accelerated aging phenotype seen in
HGPS patients, and also possibly a model for physiological
aging, is that adult stem cell dysfunction leads to a progressive
deterioration of tissue functions. One of the earliest effect
of progerin expression is the activation of several Notch
cell–signaling pathway components, interfering with the
normal function of human mesenchymal stem cells (Scafﬁdi
and Misteli, 2008). The Notch cell–signaling pathway is an
evolutionarily conserved major regulator of stem-cell differ-
entiation and cell fate that is key to maintaining adult
tissue homeostasis (Okuyama et al., 2008). The induced
epidermal expression of the human p.G608G mutation in
mice was shown to decrease adult stem cell populations in
the skin, causing impaired wound healing. Biopsy wounds
(3 mm) were examined 4 and 7 days after wounding and
were found to have uneven and disorganized wound
edges and disrupted reepithelialization in progeroid mice
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Figure 2. Histopathology of progerin expression. (a) Disease severity increases with higher levels of progerin. (b–d and f–h) K5 (green), DNA (blue). (b and f)
Mouse lamin (La) A/C (red) is expressed by E17.5. (c and g) Epidermal progerin expression (red), wild-type (c) and progeroid (g) E17.5. Progerin expression follows
K5 expression (g). (d and h) Adult wild-type (d), progeroid (h) mouse skin, progerin (red) showing epidermal hyperplasia and hyperparakeratosis (h).
(e and i) Hematoxylin and eosin (H&E) staining of wild-type (e) and progeroid (i) mouse skin. (j and k) Impaired wound healing. A 3mm wound site from
wild-type (j) and progeroid (k) mice 7 days after wounding. K5 (blue), dividing cells (red). Disorganized wound edges, delayed reepithelialization, and
(inset) increased cell proliferation at wound edges in k. Dashed lines indicate wound centers. Scale bars (b–i)= 20 μm, (j and k)=200 μm.
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compared with wild-type mice (Figure 2k). The impaired
keratinocyte migration may have been caused by the reduced
expression of b1- and a6-integrins in cells from progeriod
mice compared with wild-type mice. Primary keratinocytes
from these animals showed a diminished proliferative
potential and ability to form colonies. The epidermal stem
cell maintenance protein p63 was also found to be down-
regulated, and an accompanying activation of DNA repair
and premature senescence was implicated as the cause of this
loss of adult stem cells (Rosengardten et al., 2011). The in vitro
experiments have also supported these ﬁndings, showing
that progerin causes signiﬁcant disruption to functions critical
to a healthy stem cell population, such as self-renewal,
proliferation, migration, and membrane ﬂexibility (Pacheco
et al., 2014).
INFLAMMATION AND SENESCENCE IN HGPS
Targeted expression of progerin in the skin resulted in dermal
ﬁbrosis and a marked inﬂammatory cell invasion, as well as a
strong upregulation of multiple genes in major inﬂammatory
pathways (Sagelius et al., 2008; Rosengardten et al., 2011).
Exon array studies have also shown inﬂammatory responses
in both HGPS and senescent ﬁbroblasts (Csoka et al., 2004).
The cardiovascular tissues of HGPS patients showed regions
exhibiting strong inﬂammation, as well as macrophage
inﬁltration (Olive et al., 2010).
The NF-κB pathway has been shown to be constitutively
hyperactivated in transgenic mice carrying the LmnaG609G
mutation (Osorio et al., 2012). The ectopic expression of LMNA
c.1824C4T in mouse skin during embryogenesis and early
development state also resulted in an activated NF-κB and the
upregulation of multiple inﬂammatory response genes
(McKenna et al., 2014). Inﬂammation and senescence have
been related as it has been demonstrated that senescent cells
secrete inﬂammatory factors known as “senescence-associated
secretory phenotype” or SASP (Coppé et al., 2008). These SASP
factors are upregulated in the LMNAG608G progeroid mouse
model (Rosengardten et al., 2011) that also showed increased
senescence-associated β-galactosidase staining in the interfolli-
cular epidermis. p63, a member of the p53 family that is
necessary for the normal development and differentiation
of the skin, was downregulated in this same model, suggesting
a link between p63 expression, NF- κB signaling, and SASP
(Rosengardten et al., 2011).
Lamin B1 reduction has been associated with keratinocyte
senescence, and decreased level of LMNB1 has been shown
as a characteristic of HGPS ﬁbroblasts (Dreesen et al., 2013).
The expression of HGPS mutation in mice showed an
increase in the ratio of basal to suprabasal expression in
the very early stages of the disease development (McKenna
et al., 2014). Other characteristics of HGPS senescent
cells are a high rate of apoptosis (Bridger and Kill, 2004)
and an increased DNA damage (Liu et al., 2005). In addition,
keratinocytes isolated from mice with targeted expression of
progerin in the skin showed higher frequency of cells with a
high number of γ-H2AX foci that is indicative of DNA damage
and/or impaired DNA repair mechanism (Rosengardten et al.,
2011).
IMPAIRED SKIN DIFFERENTIATION AND MISREGULATED
GENE EXPRESSION
Mice overexpressing progerin showed halted skin development,
severe inﬂammation, mislocalization of K5 in the suprabasal
layers of the epidermis, and maintenance of lamin B receptor
(LBR) in the more differentiated suprabasal layers (McKenna
et al., 2014). This indicated that progerin expression resulted in
impaired skin differentiation and a possible role for LBR in the
progeroid phenotype progress. A new study carried out in our
lab, in which ectopic expression of LBR was induced in mouse
skin (Sola Carvajal et al., 2015), did not recapitulate the
phenotype seen in our previous model (McKenna et al., 2014),
suggesting that LBR is not the only contributor to the progeroid
phenotype. However, LBR-expressing mice also showed
impaired skin differentiation with mislocalization of K5 in the
suprabasal layers of the epidermis and, interestingly, down-
regulation of K10 that was not previously described in progeroid
mice. Possibly reduced expression of K10 has been observed
during normal skin aging and keratinocyte differentiation in
human skin (Dreesen et al., 2013). In these LBR-expressing
mice, and lamin A G608G progeroid mice (Figure 2b and i), a
high frequency of the LBR-expressing cells had a more
condensed DNA distribution with increased number of γ-
H2AX foci (McKenna et al., 2014; Sola Carvajal et al., 2015), in
agreement with another recent study that demonstrated that
DNA localization and condensation can activate DNA damage
response (Burgess et al., 2014). Other progeroid mouse models
have shown skin abnormalities. Mice lacking Zmpste24
presented progressive hair loss as well as atrophic epidermis
and hair follicles and increased apoptosis (Bergo et al., 2002;
Pendás et al., 2002), whereas the model carrying the HGPS
mouse mutation (G609G) showed a loss of the subcutaneous fat
layer and of hair follicles (Osorio et al., 2011).
Solovei et al. (2013) showed that LBR and lamin A mediate
heterochromatin localization and tethering to the nuclear
lamina in a developmental state–dependent way. Thus,
heterochromatin is directly bound to the nuclear lamina and
many transcription factors. As primary ﬁbroblasts isolated from
HGPS patients display loss of peripheral heterochromatin
(Goldman et al., 2004), the capacity of progerin to disrupt
normal heterochromatin localization and to cause transcrip-
tion factor mislocalization is therefore thought to cause the
misregulated gene expression found in HGPS cell lines (Csoka
et al., 2004). Chromatin immunoprecipitation experiments
of cells overexpressing progerin and lamin A revealed that
lamin-interacting promoters lack a unique consensus binding
sequence and that the expression of progerin or lamin A
does not induce changes in the gene expression pattern of
lamina-associated genes (Kubben et al., 2012). However,
another chromatin immunoprecipitation experiment in HGPS
ﬁbroblasts using anti-lamin A antibodies showed that nuclear
disruption caused by progerin accumulation produces changes
in the chromatin–lamina association, as well as redistribution of
the H3K27me3 heterochromatin mark. These modiﬁcations in
the nuclear architecture lead to changes in the gene expression
and loss of spatial chromatin compartmentalization (McCord
et al., 2013).
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CONCLUSIONS AND FUTURE DIRECTIONS
The emerging picture of lamin A as a part of a sensory tool for
detecting forces external to the cell and relating that information
to the nucleus is sure to give a greater understanding to the
disease mechanisms of laminopathies. Lamin A has also been
shown to have a key role in tissue stiffness and tissue matrix–
directed cell differentiation, where lamin A knockdown
enhanced mesenchymal stem cell differentiation on a soft
matrix to low stress, fat phenotype tissues, whereas lamin A
overexpression enhanced cell differentiation on stiff matrix to
higher stress, bone phenotype tissues (Swift et al., 2013). These
results might explain the speciﬁcity of certain HGPS disease
pathologies to tissues such as the bone or smooth muscle.
Advances have been made in the treatment of HGPS
patients in a clinical trial mainly focused in the use of
farnesyl transferase inhibitor lonafarnib (Gordon et al., 2012).
This suggested improvements in vascular stiffness, and by
comparing survival proﬁles an increased lifespan was noted
(Gordon et al., 2014).
Future studies including the effects of lamin mutations on
speciﬁc cell types, not only using appropriate models but also
assessing effects on a global scale, will certainly continue to
move the ﬁeld forward.
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